American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
David G. Pfister(Memorial Sloan Kettering Cancer Center), Gregory T. Wolf(University of Michigan), William M. Mendenhall(Florida College), David J. Adelstein(Cleveland Clinic), Arlene A. Forastiere(Greater Baltimore Medical Center), Susan G. Fisher(NorthShore University HealthSystem), Scott A. Laurie(Ottawa Hospital), Snehal G. Patel(Nirma University), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Michael Schwartz(American Society of Clinical Oncology), Jean‐Louis Lefebvre(American Society of Clinical Oncology), Louis B. Harrison(St. Luke's-Roosevelt Hospital Center), Marcy A. List(American Society of Clinical Oncology), Gregory S. Weinstein(University of Pennsylvania), Bernard O’Malley(American Society of Clinical Oncology), Gary L. Clayman(Tampa General Hospital), K. Kian Ang(Third Affiliated Hospital of Southern Medical University), Nancy E. Leupold(American Society of Clinical Oncology)
Cited by 504
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k